Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Lantheus Holdings, Inc.

< Previous 1 2 3 Next >
News headline image
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present at March 2026 Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces Leadership Transition Plan
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present at the 2025 Truist Securities MedTech Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
News headline image
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Tickers LNTH
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.